Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. - Wikidata - awgldk - TriplyDB

Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse.

Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse.

http://www.wikidata.org/entity/Q45309204

about

T cell-depleted hla-haploidentical stem cell transplantation in thalassemia young patients How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?Review on Haploidentical Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies The role of NK cells in HIV-1 protection: autologous, allogeneic or both?NK Cell and CD4+FoxP3+ Regulatory T Cell Based Therapies for Hematopoietic Stem Cell Engraftment Intensive care outcomes in adult hematopoietic stem cell transplantation patients Myeloablative Conditioning with PBSC Grafts for T Cell-Replete Haploidentical Donor Transplantation Using Posttransplant Cyclophosphamide Haploidentical Hematopoietic Stem Cell Transplantation: Expanding the Horizon for Hematologic Disorders Critical Role of Tumor Microenvironment in Shaping NK Cell Functions: Implication of Hypoxic Stress Modern approaches to HLA-haploidentical blood or marrow transplantation Alternative Donor Transplantation for Acute Myeloid Leukemia Effects of T-Cell Depletion on Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in AML Patients Preventing stem cell transplantation-associated viral infections using T-cell therapy Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantation Some aspects of allogeneic stem cell transplantation in patients with myelodysplastic syndrome: advances and controversy Advances in haplo-identical stem cell transplantation in adults with high-risk hematological malignancies The role of gamma delta T cells in haematopoietic stem cell transplantation Functional Reconstitution of Natural Killer Cells in Allogeneic Hematopoietic Stem Cell Transplantation Immunity to Infections after Haploidentical Hematopoietic Stem Cell Transplantation Haploidentical hematopoietic transplantation without T-cell depletion: current status and future perspectives Alternative Donor Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia Haploidentical Hematopoietic Stem Cell Transplantation as a Platform for Post-Transplantation Cellular Therapy Haploidentical transplantation of hematopoietic stem cells.Outcomes of haploidentical transplant compared with matched donor allogeneic stem cell transplant.Pilot study of a (213)bismuth-labeled anti-CD45 mAb as a novel nonmyeloablative conditioning for DLA-haploidentical littermate hematopoietic transplantation.Donor-Specific Anti-Human Leukocyte Antigen Antibodies Predict Prolonged Isolated Thrombocytopenia and Inferior Outcomes of Haploidentical Hematopoietic Stem Cell Transplantation.Improving cytomegalovirus-specific T cell reconstitution after haploidentical stem cell transplantation Induction of tolerance to bone marrow allografts by donor-derived host nonreactive ex vivo-induced central memory CD8 T cells.Ex vivo T cell-depleted versus unmodified allografts in patients with acute myeloid leukemia in first complete remission.Improved survival with inhibitory killer immunoglobulin receptor (KIR) gene mismatches and KIR haplotype B donors after nonmyeloablative, HLA-haploidentical bone marrow transplantation Treating human autoimmunity: current practice and future prospects Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene Evaluation of bone marrow mononuclear cells as an adjunct therapy to minced muscle graft for the treatment of volumetric muscle loss injuries.Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT.Biology and clinical effects of natural killer cells in allogeneic transplantation.Haplo is the new black.Allogeneic hematopoietic cell transplantation: the state of the art Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor Haploidentical vs cord blood transplantation for adults with acute myelogenous leukemia.Adoptive transfer of unselected or leukemia-reactive T-cells in the treatment of relapse following allogeneic hematopoietic cell transplantation.

P2860

Q24632544-25B0DA47-3DFD-4262-A8C5-197F5ADEAB93 Q26748867-C097B68A-12D0-4670-ADD0-C2DFD0493769 Q26749120-E2646864-0094-408E-9EC7-E3F86CAF87FB Q26753146-51EEE955-A344-4FEA-8E85-8C84D7881AFF Q26765845-DBC69EB8-962F-4CA6-BEF9-A082E1C71E55 Q26767031-95FE750F-C849-4BB6-A3D2-FAE611788993 Q26767438-86B4FF28-A1F5-487F-BFB6-195E43859BF2 Q26767501-396E1752-45BA-4695-B5A0-A0BD4F614F60 Q26781260-4D695959-F822-480F-BC84-0F584C854085 Q26797506-C28EA991-1133-446F-B580-499B5471B90C Q26799456-98E74AE6-3606-4DC3-AF58-C39B4F4A2F63 Q26799602-5B324483-C62A-4AC0-8794-B978616EFDEB Q26801365-6401F34C-5C68-4808-A671-72D566146DD9 Q26852474-6D6612D8-FCC4-475C-A795-73705B8E38FA Q27010653-17F3B17C-2520-42A6-BABB-4AC49E7379D1 Q27014857-9D2F4BB4-5146-4A91-BED5-7800FBBD8FF6 Q27030355-5F0EF216-19CF-4888-AC9D-4D1703ABECFC Q28069682-A1A1B401-C452-4FA3-8C36-8E4C68EDAD44 Q28079606-BCBB17B7-2EDD-4F93-8465-3CB44FC35DEE Q28080452-32E5F664-65C7-4079-9C58-0AC3B23328A2 Q28080943-0C159E07-8F07-4555-A7AA-25322D916B00 Q28085397-4BD6733E-3133-4F58-A0A6-ADE1D2F19ACE Q30240041-E2EA663D-B32E-4E22-AF6E-665283135A39 Q30240140-E3D105DF-AF26-4824-9C72-802F0C08A96F Q33388983-9F8256F9-30A5-41EF-971A-9B6FBAB5C182 Q33441698-85AEB323-E6B9-46DE-8D8F-1EB082CC8911 Q33597783-A749A131-8AE9-4840-AC77-69F57D65F0D7 Q33722672-3957E6A8-C5E4-494D-A0B9-2B064F29ED87 Q33760933-B2E922CD-FC3C-49A4-89CE-FC47045DE5CE Q33765556-66907C8B-A1B7-4CF3-B976-941FCADAB516 Q33772444-2BB99D27-84DC-4BDB-A18D-EF638CF1B932 Q33781162-60FE3C40-AEEF-4FF0-9F3E-6A7C487530B3 Q33784964-74D4B0A2-1239-4F85-A5E0-9988B3D9F76C Q33841389-BADDABC2-E6EA-4EC5-BA92-9727B4ECFE42 Q33893173-F0F28962-1EEC-41C2-9C19-27D0A91F769A Q33987066-3DF46E22-62C4-4CCE-9EA7-EA3439469B72 Q34145155-940AAFB3-DBC4-4117-AFB4-4AF8FCAB83A2 Q34231837-AAC8E56E-D120-4F15-AC76-958AB705B31F Q34232835-E1EEBD61-336E-44D3-87AF-095F539C1DA9 Q34279672-98A18390-BB01-406E-BCD0-58C0DD51F876

P2860

Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse.

http://www.wikidata.org/entity/Q45309204

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Full haplotype-mismatched hema ...... kemia at high risk of relapse.

@en

Full haplotype-mismatched hema ...... kemia at high risk of relapse.

@nl

type

label

Full haplotype-mismatched hema ...... kemia at high risk of relapse.

@en

Full haplotype-mismatched hema ...... kemia at high risk of relapse.

@nl

prefLabel

Full haplotype-mismatched hema ...... kemia at high risk of relapse.

@en

Full haplotype-mismatched hema ...... kemia at high risk of relapse.

@nl

P1433

Q45309204-328256E8-6C8E-4B6F-B021-476987D8B042

P1476

Q45309204-B53575FE-7B4F-4AD6-9790-2E2138FEF50A

P2093

Q45309204-19E8D5AF-57E4-4DDE-8E56-573FD727F228

Q45309204-2CD442BF-19B0-4F32-9584-F77E9937B0A1

Q45309204-4D6EF449-1131-4751-87A9-162BD1467E1B

Q45309204-66868A92-F012-4C6D-9189-EB79A25272DD

Q45309204-7035E568-22FF-451B-BEA6-D12E70ED7050

Q45309204-70B17225-9FB9-4108-9D48-F1F59B5F98AD

Q45309204-7908417B-93CC-41B0-9A2F-C4FD62A3C968

Q45309204-A08109F6-7DA0-444F-80EF-87EF2B1EBC20

Q45309204-A21F884E-EC98-404E-8F92-0B4B9E298C23

Q45309204-C9B936AA-7150-486A-AEAA-D647DBB33145

P304

Q45309204-988DFE77-F5A1-407D-970F-A40DE53A760E

P31

Q45309204-4FE06C81-14AE-427C-A3E4-0CEF1B047F85

P356

Q45309204-35900E5F-0E11-465D-B9BD-8DFD3465BAAA

P407

Q45309204-8C1E8438-2ED0-4239-BFC6-E406BC78B47D

P433

Q45309204-569A91CA-28E5-4302-BDC2-FB2F5AFD067C

P478

Q45309204-06F463AE-BFBC-4CBE-B75D-1247C5A97643

P50

Q45309204-1817CC22-653A-4838-A6A3-27813057D693

Q45309204-58386BFA-B53C-4B50-BFFC-BEAC6B82FC5F

P577

Q45309204-257BF90A-6992-4DE9-BA49-20B64B3CBD11

P698

Q45309204-31BC4C79-0774-4378-AC9D-60E73223C0FD

P921

Q45309204-12BF3144-BB3B-4E8F-BD81-6FEB08A3C670

Q45309204-2D1ED649-BC76-4B80-A7FA-8CA73996DED6

P356

JCO.2005.09.117

P1433

Journal of Clinical Oncology

P1476

Full haplotype-mismatched hema ...... ukemia at high risk of relapse

@en

P2093

Adelmo Terenzi

http://www.w3.org/2001/XMLSchema#string

Alessandra Carotti

http://www.w3.org/2001/XMLSchema#string

Andrea Velardi

http://www.w3.org/2001/XMLSchema#string

Antonella Santucci

http://www.w3.org/2001/XMLSchema#string

Antonio Tabilio

http://www.w3.org/2001/XMLSchema#string

Cristina Mecucci

http://www.w3.org/2001/XMLSchema#string

Flavio Falcinelli

http://www.w3.org/2001/XMLSchema#string

Franca Falzetti

http://www.w3.org/2001/XMLSchema#string

Jean Pierre Saab

http://www.w3.org/2001/XMLSchema#string

Katia Perruccio

http://www.w3.org/2001/XMLSchema#string

P304

3447-3454

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2005.09.117

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-03-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15753458

http://www.w3.org/2001/XMLSchema#string

P921